Monday, March 23, 2026 3/23/2026

Use of the KF Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment

Award Number: R01AG073235
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/15/2022
PERIOD OF PERFORMANCE END DATE: 11/30/2027

Group Awards By:

View Award Description

Use of the KF Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment - Project Summary Prevalence rates for Mild Cognitive Impairment (MCI) range from 7-25% for adults over the age of 60, with risk increasing with age. Impairments in new learning and memory (LM) are common in persons with MCI and negatively impact several aspects of everyday life, including independence in daily activities and social functioning. Despite the demand for LM treatments by older adults and clinicians alike, few cognitive rehabilitation (CR) protocols to date are supported by Class I research evidence, thereby limiting the degree to which potentially efficacious treatments can be applied to individuals with MCI. The Kessler Foundation modified Story Memory Technique (KF-mSMTTM) is a manualized, 10-session CR protocol designed to treat impaired LM. Over a decade of research and development conducted at our center has demonstrated the KF-mSMT to be effective for improving LM in individuals with neurological conditions (e.g., MS, TBI), across three realms of functioning (objective behavior, neural functioning, and everyday life) with improvements maintained over time. This convincing data provides Class I evidence supporting the efficacy of the KF-mSMT for improving LM in these populations. In addition, we have accumulated strong pilot data on the efficacy of the KF-mSMT in individuals with MCI, highlighting the likely successful application of the KF-mSMT to individuals with MCI. We will conduct a multi-site, double-blind, placebo-controlled randomized clinical trial (RCT), administering the KF-mSMT to 120 participants who meet criteria for MCI. Outcome will be assessed immediately following treatment, 6 months following treatment as well as 18 months following treatment to examine the long-term impact. Outcome will be measured via 3 mechanisms: (1) Neuropsychological Evaluation (NPE) to examine post-treatment changes on objective cognitive performance (2) Assessment of Global Functioning (AGF) to examine post-treatment changes in cognition in daily life and (3) functional magnetic resonance imaging (fMRI) to examine pre to post-treatment changes in patterns of cerebral activation underlying LM performance. The examination of daily life activities as an a priori endpoint in this RCT is a highly innovative aspect of the proposed work, highlighted as a significant gap in the rehabilitation literature by many experts in CR. Importantly, the rigorous research design employed in the current study is highly responsive to the objectives set forth by the NIA in their strategic directions (p.14), to “determine how individuals can maintain function with age or regain that function after loss due to immobility, illness, or trauma”, while also designed to identify the “mechanism through which common interventions, both medical and behavioral, may slow the physical and cognitive decline.”


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $640,136 )
2026	2026	KESSLER FOUNDATION, INC	120 EAGLE ROCK AVE STE 100	EAST HANOVER	NJ	07936	MORRIS	USA	Aging Research	000	4	3/3/2026	NON-COMPETING CONTINUATION	$640,136
														Subtotal = $640,136

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	KESSLER FOUNDATION, INC	120 EAGLE ROCK AVE STE 100	EAST HANOVER	NJ	07936	MORRIS	USA	Aging Research	000	3	7/14/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $646,943 )
2024	2024	KESSLER FOUNDATION, INC	120 EAGLE ROCK AVE STE 100	EAST HANOVER	NJ	07936	MORRIS	USA	Aging Research	000	3	7/5/2024	NON-COMPETING CONTINUATION	$646,943
														Subtotal = $646,943

Issue Date FY: 2023 ( Subtotal = $560,518 )
2023	2023	KESSLER FOUNDATION, INC.	120 EAGLE ROCK AVE STE 100	EAST HANOVER	NJ	07936	MORRIS	USA	Aging Research	000	2	5/23/2023	NON-COMPETING CONTINUATION	$560,518
														Subtotal = $560,518

Issue Date FY: 2022 ( Subtotal = $599,831 )
2022	2022	KESSLER FOUNDATION, INC.	120 EAGLE ROCK AVE STE 100	EAST HANOVER	NJ	07936	MORRIS	USA	Aging Research	001	1	8/24/2022	NEW	-$599,831
2022	2022	KESSLER FOUNDATION, INC.	120 EAGLE ROCK AVE STE 100	EAST HANOVER	NJ	07936	MORRIS	USA	Aging Research	002	1	8/30/2022	NEW	$599,831
2022	2022	KESSLER FOUNDATION, INC.	120 EAGLE ROCK AVE STE 100	EAST HANOVER	NJ	07936	MORRIS	USA	Aging Research	000	1	8/12/2022	NEW	$599,831
														Subtotal = $599,831

Grand Total All Awards = $2,447,428

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Use of the KF Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment

Award Number: R01AG073235

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/15/2022

PERIOD OF PERFORMANCE END DATE: 11/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer